Skip to search formSkip to main contentSkip to account menu

Mysoline

Known as: Draxis Brand of Primidone, Xcel Brand of Primidone, AstraZeneca Brand of Primidone 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1973
1973
  • A. RundleB. Sudell
  • 1973
  • Corpus ID: 11376684
Review
1968
Review
1968
Epileptic disorders of unknown cause in Jerusalem, Israel, which were diagnosed during the period January, 1958, through December… 
1966
1966
PRIMIDONE (Mysoline) has been shown to be an effective anticonvulsant drug. 1-6 It has been stated that primidone is… 
1961
1961
The results of treatment of epilepsy in 282 patients hospitalized and subsequently followed in an outpatient department are… 
1957
1957
In the past two years, 15 cases of megaloblastic anemia occurring in patients undergoing anticonvulsant treatment with either… 
1954
1954
An appreciable number of patients with seizures are not helped by the standard anticonvulsants. There is, therefore, a constant… 
1953
1953
Mysoline* is a new anticonvulsant which was first prepared and evaluated by us and subse-quently subjected to clinical trial… 
1953
1953
MYSOLINEt is a recent addition to the family of drugs recommended in the treatment of epilepsy. Some pharmacological aspects of… 
1953
1953
THE PURPOSE of this study was to observe the effects of a new anticonvulsant called Mysoline in a series of 30 epileptic patients…